Hi, what are you looking for?

Global Digital Pathology Market– Overview

Digital pathology fuses the procurement, management, sharing and translation of pathology data – including slides and information – in a digital climate. Digital slides are made when glass slides are captured with a scanning gadget, to give a high-goal digital picture that can be seen on a PC screen or cell phone.

Global digital pathology Market size was $736 billion in 2021, and is anticipated to grow to a value of more than $1873 billion by 2030, registering a growing CAGR (Compound annual growth rate) of over 13% from 2022 to 2030.

Global Digital Pathology Market- Key Trends

One of the major driving factors of the global digital pathology market is the rise in generic and rapid technological advancements in digital pathology system. This factor has boosted the market growth over the forecast duration.

Also, the rise in number of cancer cases is another factor that is increasing the market growth. The rise in chronic and cardiovascular diseases acts as another factor boosting the market growth.

The use of Artificial Intelligence (AI) has also proven to be more effective than previous techniques used in identifying and evaluating pathological characteristics. The implementation of AI has helped in accelerating and strengthening diagnosis and also in making the process of drug discovery more successful and cost-efficient. This has boosted the digital pathology market over the forecast year.

It is also seen that digital pathology has played an important role in companion diagnostics and drug development pipelines that includes molecular biology, bio banking, molecular tissue profiling, and tissue microarray analysis. The increase in demand for high-quality tissue samples in tissue-based biomarker research is projected to propel the adoption of digital pathology over the forecast period.

Request a Free Sample Copy: https://wemarketresearch.com/sample-request/digital-pathology-market/62/

Segmentation Analysis of Global digital pathology Market

The device section leads the market in 2021 and represented the biggest income share of over 50% in 2021. The device segment incorporates scanner and slide the executives’ frameworks. Expanding reception for academic research activities and upgraded goal are the key development drivers of the section.

The academic research application segment represented the biggest share of over 45% of the worldwide income in 2021 and is projected to grow further at a consistent CAGR from 2022 to 2030.

The hospitals segment represented the biggest income share of over 36% in 2021 attributable to the high reception of digital scanning techniques in emergency clinics for quicker analysis and better persistent consistence.

North America is anticipated to hold the largest market share

North America, Europe, Latin America, Asia Pacific, and Middle East and Africa are the major regions constituting the geographical landscape of Global digital pathology Market. North America held the largest share of the digital pathology market in 2020 and is expected to grow further. The rising pervasiveness of chronic diseases, growing interest for quality diagnostics, the presentation of ideal repayment policies, and the execution of positive drives by the legislatures in the US and Canada are main considerations driving the development of the digital pathology market in North America.

The Key players in the Global digital pathology Market are Leica Biosystems, Koninklijke Philips N.V, 3D-Histech Ltd, Apollo Enterprise Imaging, F. Hoffmann-La Roche Ltd, Visiopharm A/S, Hamamatsu Photonics K.K, Corista, Ventana Medical Systems, Inc, and Huron Digital Pathology Inc.

In April 2021, Leica Biosystems joined forces with Paige to coordinate its digital pathology stage with the last’s AI-empowered research oncology programming. This would stretch out admittance to computational pathology items for translational and clinical in select nations across the North America and Europe locales.

Likewise in April 2021, Philips banded together with Ibex Medical Analytics to consolidate its digital pathology solutions with the latter’s AI-fueled Galen stage, hence improving its contributions. While Oxford University Hospitals Cellular Pathology department finished 100 percent digitization of histology slides with the assistance of Philips.

For more information about this report visit:- https://wemarketresearch.com/reports/digital-pathology-market/62/  

Major questions answered in this report

Key takeaways from the report-

We Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. We Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

15 percent of people aged 40-75 have a form of undiagnosed high blood pressure (or hypertension) that occurs only at night-time.

100 percent of pay for 80 percent of the time. Sounds good?

Go out and vote to protect your rights, top Italian designers urged compatriots this week as the Milan shows coincided with elections.

On the half-ruined top floor of an apartment block in war-scarred Irpin near Kyiv, Mr. Kyrylenko looks proudly at the new roof taking shape.

COPYRIGHT © 1998 - 2022 DIGITAL JOURNAL INC. Sitemaps: XML / News . Digital Journal is not responsible for the content of external sites. Read more about our external linking.